Helena F. Florindo

PhD (2008) in Pharmacy (Pharmaceutical Technology), Universidade de Lisboa

Assistant Professor, Pharmaceutics and Pharmaceutical Technology

Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal

T (+351) 217946429
F (+351) 217 946 470
Researcher ID E-7913-2012
Group Researcher ID B-4826-2014
Scopus Author ID 24402599300

Research Interests

Florindo’s research is focused on the development of multivalent nanotechnology-based systems to modulate the recognition, capture, processing and presentation of cancer antigens by dendritic cells. It includes the in vitro and in vivo studies of the anti-tumor effects induced by the combination of these nanovaccines with nanotherapeutics designed to modulate the function and activation of other key cells within tumor site, such as T cells, myeloid-derived cells and tumor cells.

Selected Publications

Silva JM, Zupancic E, Vandermeulen G, Oliveira V, Salgado A, Videira M, Gaspar M, Graça L, Préat V, Florindo HF. In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumour immune responses in a melanoma model. J Control Release 2015; 198C; 91-103.

Zupančič E, Curato C, Paisana M, Rodrigues C, Porat Z, Viana AS, Afonso CA, Pinto J, Moreira JN, Gaspar R, Satchi-Fainaro R, Jung S, Florindo HF. Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming. J Control Release 2017; 28: 182-195.

Silva AL, Peres C, Conniot J, Matos AI, Moura L, Carreira B, Sainz V, Scomparin A, Satchi-Fainaro R, Préat V, Florindo HF. Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation. Semin Immunol 2017; pii: S1044-5323(17)30040-4.

Santos FMF, Matos AI, Ventura AE, Gonçalves J, Veiros LF, Florindo HF, Gois PMP. Modular Assembly of Reversible Multivalent Targeting Drug Conjugates. Angewandte Chemie 2017 56(32):9346-9350.

Silva JM, Videira M, Gaspar R, Préat V, Florindo HF. Immune System Targeting by Nanoparticles for Cancer Vaccines. J Control Release 2013; 168: 179-199.